- ByInvesting.com-
Investing.com -- Amplifon SpA shares fell to their lowest level since late 2016 after the Italian hearing-aid retailer announced a...
Last | High | Low | |||||
|---|---|---|---|---|---|---|---|
| 327.7 | 328.5 | 325.7 | +4.1 | +1.27% | 134.88K | ||
| 856.8 | 866.8 | 855.0 | -10.0 | -1.15% | 22.72K | ||
| 1,650.0 | 1,653.5 | 1,634.0 | +8.5 | +0.52% | 25.13K | ||
| 243.3 | 247.0 | 241.4 | -5.9 | -2.35% | 2.02M | ||
| 18,205 | 18,280 | 17,860 | +205 | +1.14% | 6.14K | ||
| 354.5 | 358.7 | 353.3 | -2.9 | -0.81% | 52.14K | ||
| 17,730 | 17,790 | 17,350 | +260 | +1.49% | 3.64K | ||
| 818.0 | 822.5 | 799.0 | +18.0 | +2.25% | 49.98K | ||
| 1,723.5 | 1,733.5 | 1,712.5 | +10.5 | +0.61% | 6.91K | ||
| 504.0 | 504.0 | 488.8 | +18.4 | +3.79% | 20.96K | ||
| 158.7 | 159.3 | 157.4 | -0.2 | -0.09% | 251.06K | ||
| 187.0 | 189.5 | 184.3 | +0.8 | +0.43% | 112.46K | ||
| 158.1 | 158.1 | 156.4 | +1.7 | +1.09% | 196.24K | ||
| 455.4 | 461.0 | 453.6 | -1.5 | -0.33% | 36.9K | ||
| 877.5 | 879.0 | 866.0 | -5.0 | -0.57% | 24.96K | ||
| 440.3 | 443.0 | 438.2 | +5.7 | +1.31% | 51.14K | ||
| 185 | 185 | 183 | +2 | +1.30% | 73.94K | ||
| 288.90 | 299.10 | 286.30 | -8.70 | -2.92% | 121.31K | ||
| 226.40 | 226.80 | 224.20 | +2.00 | +0.89% | 60.25K | ||
| 148.10 | 150.95 | 147.40 | -1.95 | -1.30% | 275.72K |
Investing.com -- Amplifon SpA shares fell to their lowest level since late 2016 after the Italian hearing-aid retailer announced a...
Investing.com -- BofA Securities has turned constructive on European IT services, flagging a gradual top-line recovery through...
Investing.com -- Shares in Italian hearing care group Amplifon tumbled to their lowest level in years on Tuesday, extending a...
Markets hate uncertainty, and right now there’s plenty to go around. The outbreak of the U.S.-Iran conflict, following by...
The equity tape is digesting last week’s whipsaw into the Dow Jones Industrial Average (^DJI) 50,000 milestone with a clear...
Novo Nordisk A/S experienced a dramatic stock decline following the company’s surprise pre-release of its 2026 forecast late...
No Earning Reports have been scheduled